ME/CFS
and mitochondrial disease
In diagnosing and attempting to treat Chronic
Fatigue Syndrome the physician is faced with a plethora of possible
causes. These include chronic viral infections, gut infections, and
exposure to pathological moulds (such as Aspergillus) or toxic chemicals
(such as agricultural sprays) in the environment. But alternative diagnoses
must also include the rare but devastating 'Inherited Metabolic Diseases',
particularly the ones that affect the 'Mitochondria'.
Mitochondria and energy
We inherit differing eye, hair and skin
colours from our parents - and these arise from differences in the
biochemistry or metabolism of eye and skin pigments that we inherit
from our parents. An important aspect of our metabolism includes
our mitochondria: these are the 'energy
factories' of cells throughout the body. Disorders affecting
mitochondria can be either inherited or acquired. Mitochondrial disease
and a resultant “chronic fatigue” type syndrome can be
acquired from exposure to various environmental pollutants (for example,
chronic exposure to organophosphate insecticide sprays). Inherited
mitochondrial disease often runs in the female side of the family,
but not always. Whatever the cause, mitochondrial disease can be difficult
to diagnose. This is partly because, from the doctor's point
of view, mitochondrial disease can be perplexing: it can affect many
the parts of the body, with the common characteristic that the affected
organs are particularly energy-dependent:
How are mitochondrial disorders diagnosed?
1. Look for a mutation in the gene (genetic diagnosis). This is relatively
simple if a mutation is known. But there is a complication with mitochondria.
The cells that form your body are made under the instructions of your
genes (DNA) in the nucleus of each cell. But the mitochondria in those
cells are different: they are constructed partly from DNA from the
nucleus and partly from their own mitochondrial DNA. This makes genetic
analysis complicated.
OR
2. Measure the activity of the mitochondrial protein (enzyme) that
is thought to be affected. This has its own problems, because it needs
prior knowledge (or a good guess) of what protein function has gone
wrong. Because there is usually only a small amount of tissue sample
available, the laboratory usually only gets one chance to choose the
right protein analysis.
OR
3. Examine a piece of affected tissue (for
example, muscle) using a microscope. This can be used to look for
damage indicating mitochondrial disease, for example, 'ragged red fibres' can be seen in
muscle by light microscope, and abnormal mitochondria can be seen by
electron microscope. This doesn't usually tell the doctor what
is actually wrong - it only confirms that mitochondria are implicated.
OR
4. In some cases, changes in the chemistry
of mitochondria caused by a disorder can be spotted by changes in
the body's chemistry.
For example, the mitochondrial disorders often (but not always) cause
an abnormal build up of a chemical, lactic acid, in cells. This can
leak out into the bloodstream and can even be detected in urine.
There are two serious difficulties with diagnosing mitochondrial disorders:
(a) A phenomenon known as 'heteroplasmy'. This refers
to the fact that mitochondria are not necessarily the same all through
the body. For example, a leg muscle may have some cells with damaged
mitochondria and normal normal cells. Even within a single cell, there
may be some normal and some diseased mitochondria. This makes it difficult
for a hospital laboratory to rely on a sample of mitochondrial DNA
or protein as representing the patient's condition elsewhere
in the body.
(b) Diagnostic testing requires a 'biopsy',
that is, a piece of the affected tissue. Taking a biopsy can be unpleasant
and hazardous, so doctors are generally reluctant to do so unless
they have a strong suspicion of a mitochondrial disorder. Even then,
the biopsy suffers the problem of heteroplasmy - the piece of tissue
may be from healthy tissue surrounding the affected tissue.
MNGIE: an example of a mitochondrial disease
MNGIE stands for 'mitochondrial neurogastrointestinal encephalopathy.' Its
name implies it primarily affects nerve cells (neurones), the gastric
and intestinal system, and the brain. It is characterised by loss of
eye muscle control, drooping eyelids, limb weakness and cramps, and
digestive problems including chronic diarrhoea or constipation and
abdominal pain. 'Borborygmi' (loudly grumbling bowels)
seems a common feature early in life. It is a serious mitochondrial
disorder and usually culminates in severe bowel obstruction and death
in the early 20's. Fortunately it is rare and may represent only
a small fraction of chronic fatigue and mitochondrial disease.
MNGIE is diagnosed fairly easily and unambiguously by measuring accumulation
of two abnormal chemicals - deoxyuridine and thymidine - in urine or
blood, plus other chemical (metabolic) clues. In Australia the test
is presently available at the Pathology Department of the Brisbane
Mater Hospital as well as other Australian capital cities.
In conclusion, there seem to be big advances
coming (finally!) in understanding ME/CFS, using powerful new genetic
techniques such as 'microarray' analysis.
These new results are pointing primarily towards two aspects: the body's
ability to fight infection, and mitochondria function. But for diagnosing
ME/CFS, we need first to carefully exclude other genetic and metabolic
disorders such as MNGIE or other mitochondrial diseases. Failure to
distinguish patients with other diseases from ME/CFS will decrease
the power of any future genetic studies and slow progress of future
research aimed at explaining ME/CFS.